111, Inc. (YI)
YI Stock Price Chart
Explore 111, Inc. interactive price chart. Choose custom timeframes to analyze YI price movements and trends.
YI Company Profile
Discover essential business fundamentals and corporate details for 111, Inc. (YI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
12 Sept 2018
Employees
1.24k
Website
https://www.111.com.cnCEO
Junling Liu
Description
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
YI Financial Timeline
Browse a chronological timeline of 111, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Aug 2026
Earnings released on 4 Jun 2026
EPS came in at -$0.60 , while revenue for the quarter reached $342.26m .
Earnings released on 9 Apr 2026
EPS came in at -$0.20 , while revenue for the quarter reached $403.17m , missing expectations by -32.76%.
Earnings released on 17 Dec 2025
EPS came in at -$0.20 , while revenue for the quarter reached $421.47m , missing expectations by -23.54%.
Earnings released on 17 Sept 2025
EPS came in at -$0.40 , while revenue for the quarter reached $447.04m , missing expectations by -14.19%.
Earnings released on 19 Jun 2025
EPS came in at -$0.20 , while revenue for the quarter reached $484.71m , missing expectations by -8.51%.
Earnings released on 20 Mar 2025
EPS came in at -$0.04 , while revenue for the quarter reached $526.99m , missing expectations by -2.78%.
Earnings released on 27 Nov 2024
EPS came in at -$0.20 , while revenue for the quarter reached $513.13m , missing expectations by -87.92%.
Earnings released on 29 Aug 2024
EPS came in at -$0.20 , while revenue for the quarter reached $471.23m , missing expectations by -3.43%.
Earnings released on 23 May 2024
EPS came in at -$0.20 , while revenue for the quarter reached $487.84m .
Earnings released on 21 Mar 2024
EPS came in at -$3.40 , while revenue for the quarter reached $580.11m .
Earnings released on 30 Nov 2023
EPS came in at -$1.60 , while revenue for the quarter reached $501.70m .
Earnings released on 24 Aug 2023
EPS came in at -$1.00 , while revenue for the quarter reached $479.98m .
Earnings released on 15 Jun 2023
EPS came in at -$0.60 , while revenue for the quarter reached $537.63m .
Earnings released on 23 Mar 2023
EPS came in at -$2.00 , while revenue for the quarter reached $605.88m .
Earnings released on 1 Dec 2022
EPS came in at -$1.60 , while revenue for the quarter reached $468.72m .
Earnings released on 16 Jun 2022
EPS came in at -$2.00 , while revenue for the quarter reached $469.42m , missing expectations by -96.88%.
Earnings released on 17 Mar 2022
EPS came in at -$2.20 , while revenue for the quarter reached $543.44m , beating expectations by +14.92%.
Earnings released on 19 Nov 2021
EPS came in at -$4.80 , while revenue for the quarter reached $518.48m .
YI Stock Performance
Access detailed YI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
